BRIEF-Pfizer Investment to Jointly Commercialize Cancer Drugs with China Resources Pharmaceutical

Reuters
26 Nov 2024
BRIEF-Pfizer Investment to Jointly Commercialize Cancer Drugs with China Resources Pharmaceutical

Nov 26 (Reuters) - Pfizer Investment Co Ltd:

  • SIGNS STRATEGIC PARTNERSHIP WITH CHINA RESOURCES PHARMACEUTICAL COMMERCIAL GROUP TO JOINTLY COMMERCIALIZE FOUR KEY DRUGS FOR BREAST AND LUNG CANCER

Source text

Further company coverage: 3320.HK

(Reporting by Beijing newsroom)

((Ella.Cao@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10